Skip to content

The effectiveness of a cardiovascular ‘health check’ in a workplace setting

Digital and remote ‘health check’ screening for cardiovascular disease in a workplace setting: a cohort study (ACHIEVE [Assessment of Cardiovascular Health – Individual EValuative Exercise])

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN42086806
Enrollment
824
Registered
2026-02-05
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases Circulatory System

Interventions

After reading this Participant Information Sheet, the employee completes the Informed Consent Form and returns it to the ACHIEVE research team using a Freepost envelope (no stamp needed). The study te

Sponsors

North Cumbria Integrated Care NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 25 – 85 years* 2. Participants in original workplace ‘baseline’ cardiovascular health check. 3. Currently still employed by one of the original employers involved in the original cardiovascular health check initiative. 4. Currently not absent from work long-term due to illness or for other reason (e.g., maternal leave, sabbatical; unless employee has explicitly indicated to employer that they can be contacted for non-work-related reasons). *In accordance with National Institute for Health and Care Excellence

Exclusion criteria

Exclusion criteria: 1. Known to have high cholesterol levels, and already being treated for this by GP and/or consultant, when participating in the original workplace ‘baseline’ cardiovascular health check* 2. Pre-existing type 1 diabetes mellitus*, chronic kidney disease (stage 3 or higher) treated with medication*, known familial hypercholesterolaemia* 3. No access to phone/tablet/computer to use the POCDOC App 4. Any reasons for the person being unable to follow the protocol, including lack of mental capacity to consent to taking part in the study (examples include dementia, patient housebound, severe learning disability). 5. The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise patient safety or study objectives (examples include receiving palliative care, medical condition that contraindicates giving routine blood samples) *In accordance with National Institute for Health and Care Excellence guidance

Design outcomes

Secondary

MeasureTime frame
1. % of original baseline volunteers consenting to be participants in the ACHIEVE study at 12 months 2. % of ACHIEVE study participants who will complete and report on the PocDoc Healthy Heart Check test at 12 months 3. Number of participants in the three main QRISK3 categories (low risk – QRISK3 score of less than 10%; moderate risk – QRISK3 score of 10-20%; high risk – QRISK3 score of more than 20%) at baseline and 12-month follow-up 4. Number of GP notifications indicated at baseline and 12 months follow-up For those participants who had a QRISK3 score of >10% at baseline: 1. % of participants who contacted and attended a GP consultation as a result at baseline 2. % of GPs who contacted the participant and invited them for a consultation (plus eventual attendance rate by participants) at baseline 3. % of participants where GP practice repeated blood lipid/cholesterol profile at baseline 4. % of participants offered lipid-modifying medication, i.e., statins, appropriately (plus eventual acceptance rate by participants) at baseline 5. % of participants investigated for high blood pressure and offered antihypertensives appropriately (plus eventual acceptance rate by participants) at baseline 6. % of participants offered weight loss advice or referral appropriately (e.g., NHS Digital Weight Management Programme for BMI =30) at baseline

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026